Abstract
Chronic hepatitis C virus (HCV) viremia has been known to provoke a plethora of autoimmune syndromes referred to as extrahepatic manifestations of chronic HCV infection. Aim of the current study was to assess the prevalence of rheumatologic manifestations among Egyptians with hepatitis C infection and its’ association with cryoglobulin profile. The current research represents a cross-sectional study where patients with chronic HCV infection attending the outpatient clinic of the National Hepatology and Tropical Medicine Research Institute over a period of 1 year were interviewed. Patients with decompensated liver disease, on interferon therapy, having end-stage renal disease or coexisting viral infection like hepatitis B surface antibody positive patients were all excluded from the research. Laboratory investigations as well as serological assay including cryoglobulin profile, rheumatoid factor, antinuclear antibody, HCV-PCR were performed. Three hundred and six patients having chronic HCV infection were interviewed in this research. The overall estimated prevalence of rheumatologic manifestations in the current research was 16.39%, chronic fatigue syndrome 9.5%, sicca symptoms 8.8%, arthralgia 6.5%, fibromyalgia 1.9%, myalgia 1.3%, arthritis 0.7%, cryoglobulinemic vasculitis 0.7%, autoimmune hemolytic anemia 0.7%, thrombocytopenia 0.7%. Xerophthalmia was significantly present in male population (p = 0.04), whereas fibromyalgia, cryoglobulinemic vasculitis, arthritis, and autoimmune hemolytic anemia were significantly present in female population under study (p < 0.05). In chronic HCV genotype 4 infection, the prevalence of rheumatologic manifestations was 16.3% with chronic fatigue syndrome and sicca sysmptoms being the most common with no significant correlation to the degree of elevation of liver disease or viral load.
Similar content being viewed by others
References
Wasley A, Alter MJ (2000) Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20(1):1–16
Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, Opolon P (1999) Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment virus C. Arthritis Rheum 42:2204–2212
Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, Yamamoto AM, Camproux AC, Hausfater P, Musset L, Veyssier P, Raguin G, Piette JC (2000) Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine (Baltimore) 79:47–56
Sterling RK, Bralow S (2006) Extrahepatic manifestations of hepatitis. Curr Gastroenterol Rep 8(1):53–59
Galossi A, Guarisco R, Bellis L, Puoti C (2007) Extrahepatic manifestations of chronic HCV infection. J Gastrointestin Liver Dis 16(1):65–73
Pascual M, Perrin L, Giostra E, Schifferli JA (1990) Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 162:569–570
Gumber SC, Chopra S (1995) Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 123:615–620
Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (2007) For the Italian Association of the Study of liver Commission on Extrahepatic Manifestations of HCV infection. Extrahepatic manifestations of hepatitis C infection: a general overview and guidelines for clinical approach. Dig Liver Dis 39:2–17
Zignego AL, Giannini C, Ferri C (2007) Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13:2467–2478
Cheney IW, Lai VC, Zhong W, Brodhag T, Dempsey S, Lim C et al (2002) Comparative analysis of antihepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. J Virol 76:1148–1154
Hepatitis C: The disease. Global alert and response. World Health Organization. Online issue October, 2009
Stefanova-Petrova DV, Tzvetanska AH, Naumova EJ, Mihailova AP, Hadjiev EA, Dikova RP (2007) Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and its association with cryoglobulinemia in Bulgarian patients. Viral hepatitis. World Journal of Gastroentrol 13(48):6518–6528
Lormeau C, Falgarone G, Roulot D, Boissier MC (2006) Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine 73(6):633–638
Rivera J, De Degio A, Trinchet M, Monforte AG (1997) Fibromyalgia-associated hepatitis C virus infection. Br J Rheum 36(9):981–985
Fadda P, La Civita L, Zignego AL, Ferri C (2002) Hepatitis C virus infection and arthritis. A clinico-serological investigation of arthritis in patients with or without cryoglobulinemic syndrome. Reumatismo 54(4):316–323
Gisbert JP, Garca-Buey L, Pajares JM, Moreno-Otero R (2003) Prevalence of hepatitis C virus infection in B-cell non-Hodgkin’s lymphoma: systemic review and meta-analysis. Gastroenterology 125:1723
Agnello V, De Rosa FG (2004) Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol 40:341–352
Antonelli A, Ferri C, Pampana A et al (2004) Thyroid disorders in chronic hepatitis C. Am J Med 117:10
Mohamed MK, Bakr I, El-Hoseiny M, Arafa N, Hassan A, Ismail S et al (2006) HCV-related morbidity in a rural community in Egypt. J Med Virol 78(9):1185–1189
Egypt: 5 million infected by hepatitis C. Online article by the Egyptian National Hepatitis Committee, Feb: 2007. Integrated Regional Information Networks IRIN
Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL (2000) Genetic epidemiology of hepatitis C virus throughout Egypt. J infect Diseas 182(3):698–707, Epub 2000 Aug 17
Larsen A (1974) A radiological method for grading the severity of rheumatoid arthritis. Academic dissertation, University of Helsinki, Helsinki
McMurray RW, Elbourne K (1997) Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 26(4):689–701
Hadziyannis SJ (1997) The spectrum of extrahepatic manifestations in hepatitis C infection. J Viral Hepat 4:9–24
Sene D, Saadoun D, Limal N, Piette JC, Cacoub P (2007) Update in hepatitis C virus associated extrahepatic manifestations. Rev Méd Interne 28:388–393
Ramos-Casals M, Muñoz S, Medina F, Jara LJ, Rosas J, Calvo-Alen J, Brito-Zerón P, Forns X, Sánchez-Tapias JM, HISPAMEC Study Group (2009) Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry). J Rheumatol 36(7):1442–1448, Epub 2009 Apr 15
Ramos-Casals M, Loustaud-Ratti V, De Vita S, Zeher M, Bosch JA, Toussirot E, Medina F, Rosas J, Anaya JM, Font J, SS-HCV Study Group (2005) Sjogren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 84:81–89
Zaltron S, Puoti M, Liberini P, Antonini L, Quinzanini M, Manni M, Forleo MA, Rossi S, Spinetti A, Zanini B, Carosi G (1998) High prevalence of peripheral neuropathy in hepatitis C virus infected patients with symptomatic and asymptomatic cryoglobulinaemia. Ital J Gastroenterol Hepatol 30:391–395
Migliaresi S, Di Iorio G, Ammendola A, Ambrosone L, Sanges G, Ugolini G, Sampaolo S, Bravaccio F, Tirri G (2001) Peripheal nervous system involvement in HCV-related mixed cryoglobulinemia. Reumatismo 53:26–32
Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M (1996) Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 24:135–140
Doi T, Homma H, Mezawa S, Kato J, Kogawa K, Sakamaki S, Niitsu Y (2002) Mechanisms for increment of platelet-associated IgG and platelet surface IgG and their implications in immune thrombocytopenia associated with chronic viral liver disease. Hepatol Res 24:23
Iga D, Tomimatsu M, Endo H, Ohkawa S, Yamada O (2005) Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia. Eur J Haematol 75:417–423
Kayali Z, Buckwold VE, Zimmerman B, Schmidt WN (2007) Hepatitis C, cryoglobulinemia, and beyond. Rheumatology (oxford) 46:572–578, no 28
Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bonkovsky HL (1995) High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21:613–619
Lamprecht P, Ahmadi-Simab K, Gross WL, Hellmich B (2006) Part 3. Research news concerning epidemiology, diagnosis, and therapy of primary systemic vasculitides. Med Klin (Munich) 101:212–225
Wu YY, Hsu TC, Chen TY, Liu TC, Liu GY, Lee YJ, Tsay GJ (2002) Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection. Clin Exp Immunol 128:347–352
Lamprecht P, Gutzeit O, Csernok E, Gause A, Longombardo G, Zignego AL, Gross WL, Ferri C (2003) Prevalence of ANCA in mixed cryoglobulinemia and chronic hepatitis C virus infection. Clin Exp Rheumatol 21:S89–S94
Buskila D, Shnaider A, Neumann L et al (1998) Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus-infected Israeli patients. Semin Arthritis Rheum 28:107–113
Pawlotsky JM, Roudot-Thoraval F, Simmonds P et al (1995) Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 122:169–173
Clifford BD, Donahue D, Smith L et al (1995) High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21:613–619
Acknowledgment
To the National Hepatology and Tropical Medicine Institute, Cairo, Egypt for giving us the ample support and facilities to achieve the study requirements.
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Additional information
Funding Agency
The research was funded by the Sustained Search Institute (SSI).
Rights and permissions
About this article
Cite this article
Mohammed, R.H.A., ElMakhzangy, H.I., Gamal, A. et al. Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians. Clin Rheumatol 29, 1373–1380 (2010). https://doi.org/10.1007/s10067-010-1463-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-010-1463-x